Mondas PLC
26 July 2006
Mondas plc ('Mondas' or 'the Company')
Mondas signs major new contract for Blue Curve.
Mondas plc, the AIM listed Financial Markets software specialist, has secured a
significant order to supply one of the world's leading banks with its market
leading Blue Curve research management software solution. The client is one of
the top ten largest banks in the world, with offices in UK, Europe, US and Asia.
The contract is for the supply of licences, professional services and support,
which, subject to acceptance, should provide material revenues in the second
half of the year.
Mondas will provide the client with the majority of Blue Curve's modules,
consisting of its create, process, comply and reach products, which will
facilitate the production and distribution of the bank's research products at
optimum levels of quality and efficiency. The client expects to see improved
levels of customer service, as well as reduced operational risk in its research
department as a result of the deployment of the software.
The project will begin immediately with a phased approach, the first of which is
due to go live in October this year. The system is proposed to be rolled out
across the bank's global offices, including those in the United States.
'I am delighted that a major UK based bank has selected Mondas for this very
important project.' said Jarlath McGee, Chief Executive of Mondas. 'Once again,
Blue Curve has shown itself to be the product of choice for improving the
operational processes of a large financial institution and underlines the
strength and the global appeal of this product.'
Mark Robertson, Director, Mondas Financial Markets Division commented: 'We are
pleased that this major bank has chosen to use Blue Curve as its research
production and delivery platform, as this demonstrates the appeal of the
software across both equity and fixed income business areas, as well as from
small to large firms.'
26 July, 2006
ENQUIRIES:
Mondas PLC Tel: 020 7392 1300
Jarlath McGee
College Hill Tel: 020 7457 2020
Alex Walters
Matthew Smallwood
Mondas Plc:
Mondas' Financial Markets Division focuses on delivering asset-servicing
solutions for global corporate actions processing, financial research and client
reporting and the management of new issues and placings. Its key products
include Radica CAPS, Signal and Venture and the Blue Curve suite of products.
Blue Curve
Blue Curve designs, builds and deploys enterprise solutions which improve the
production and distribution of complex financial documents. Founded in London in
1995 and acquired by Mondas in 2005, the company now has offices in the UK and
the US and serves customers throughout Europe, Africa and North America. Blue
Curve is the recognised leader in software applications which improve the
production and distribution of investment research, and is a major operator in
the growing investment management research and client reporting markets. For
more information, see http://www.bluecurve.net
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.